top of page

EU collaboration strengthens safety monitoring of medicines

European Commission publishes three-year report on implementation ofpharmacovigilance legislation

Closer collaboration between the European Medicines Agency (EMA), the European Commission and the EU Member States, enabled by the new Europeanpharmacovigilance legislation, has enhanced the monitoring of the safety of human medicines throughout their life cycle, for the benefit of patients. This is highlighted in theEuropean Commission report on the pharmacovigilance activities of the European medicines regulatory network published today.

Click on this link for more information.


Today's News
Follow us
  • LinkedIn Social Icon
  • Vimeo Social Icon
Newsletter on Pharma Legislation
the newsletter of
bottom of page